BeiGene is developing a pipeline of oral small molecules and monoclonal antibodies to fight cancer. Get up to date with the BeiGene solid tumor pipeline and clinical trials.
Lectura
A summary of the latest developments from 12 studies in the treatment of NSCLC, gastric cancers and other solid tumors presented at ESMO 2022.
Presentación
A video about the mode of action (MoA) of PD-1 inhibitors.
Video
Report on treatment advances in advanced solid tumors presented at ESMO 2021.
Lectura
Report on updates in the treatment of lung cancer presented at WCLC and ESMO 2021.
Lectura
